In India, timely respiratory support could help prevent 80% of newborn deaths linked to respiratory distress syndrome. And this is where Saans, a C-CAMP-supported innovation, is making a life-saving difference! SAANS, an innovation by C-CAMP startup @InnAccel, is expanding easy access to critical respiratory care for newborns — not just in urban areas, but also in low-resource and remote settings across India and beyond. It is a non-invasive, portable CPAP technology that delivers continuous positive airway pressure while monitoring Oxygen and airflow in real time, without relying on complex infrastructure. Check out this video by @GatesIndia to see how this innovation is expanding access to newborn respiratory care. Innaccel has been supported through C-CAMP's multiple funding and technology impact programmes #CCAMP #NeonatalCare #RespiratoryCare #MedTech #HealthTech #Innovation @Taslimarif_IND @PrinSciAdvOff @DBTIndia @IndiaDST @BIRAC_2012 @AIMtoInnovate @MoHFW_INDIA @meitystartuphub @GoI_MeitY @startupindia @NITIAayog @PriyankKharge @Startup_Kar @ITBTGoK @DHFWKA @WHO @WHOSEARO @gatesfoundation @GatesIndia @IPEGlobal @Infy_Foundation @Niteshtech

It's not everyday that @BillGates, Chair @gatesfoundation gives the limelight to your life-saving innovation! linkedin.com/posts/williamhg… Delighted to see CCAMP supported @Innaccel's #FetalLite AI powered fetal heart rate and labour monitor unpacked by Bill himself as he takes us through Fetal Lite's gamechanging features that make it more accurate, affordable and accessible than standard 20K USD fetal monitors. @Taslimarif_IND @MSuzman @BMGFIndia @MoHFW_INDIA @DBTIndia @BIRAC_2012 @NITIAayog @meitystartuphub @AIMtoInnovate @PrinSciAdvOff @ITBTGoK @startupindia @DPIITGoI @Pharmadept @ICMRDELHI @CDSCO_INDIA_INF @DHFWKA @InfyFoundation @Niteshtech

CCAMP #MedTech startup @innaccel gets featured by @NITIAayog for their stellar work in building multiple world-first medical devices for improving healthcare access through context-specific and outcome-driven innovation. frontiertech.niti.gov.in/sto… Their product Saans, a neonatal respiratory assistive device, has improved newborn survival rates in a deployment effort in North East India as well as in Karnataka, facilitated by C-CAMP. Innaccel's VAP Care has clinical evidence of 80% reduction in ventilator-associated pneumonia deaths in ICUs in clinical trials validated by research conducted at Nimhans Their third device, Fetal Lite, is an AI Power fetal monitor designed to enable advanced pregnancy monitoring in low-resource settings. Together, they have touched 2.75 Lakh Indian citizens in 700 hospitals across the country and delivered quality healthcare to 2 Lakh babies. @Taslimarif @Niteshtech @innaccel_india @PrinSciAdvOff @GoI_MeitY @meitystartuphub @DBTIndia @IndiaDST @BIRAC_2012 @AIMtoInnovate @ITBTGoK @startupindia @Startup_Kar @Infy_Foundation @BMGFIndia @kris_sg @kiranshaw @RenuSwarup @kvijayraghavan @prashanthp @RajanAnandan @NIMHANS_BLR

CCAMP-supported health tech startup InnAccel Technologies has crossed another major milestone! Their flagship innovation, Saans — an intelligent, multi-therapy system providing respiratory support for neonatal and pediatric patients — has received US FDA 510(k) clearance. Read more about their work: c-camp.medium.com/innaccel-a… Congratulations, team InnAccel. @innaccel @innaccel_india @Taslimarif @PMOIndia @DBTIndia @BMGFIndia @Niteshtech @WHO @MoHFW_INDIA @BIRAC_2012 @AIMtoInnovate @ITBTGoK @startupindia @Startup_Kar